For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 92,854 | |||
| In-process research and development | 9,500 | |||
| General and administrative | 38,551 | |||
| Total operating expenses | 140,905 | |||
| Loss from operations | -140,905 | |||
| Interest income | 16,607 | |||
| Other expense, net | 248 | |||
| Total other income (expense), net | 16,359 | |||
| Net loss | -124,546 | |||
| Unrealized gain on marketable securities, net | 223 | |||
| Comprehensive loss | -124,323 | |||
| Basic EPS | -0.44 | |||
| Diluted EPS | -0.44 | |||
| Basic Average Shares | 283,533,696 | |||
| Diluted Average Shares | 283,533,696 | |||
Erasca, Inc. (ERAS)
Erasca, Inc. (ERAS)